Melissa Joy Davison, MD Pain Medicine - Interventional Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 60 Business Park Dr, Troy, MO 63379 Phone: 888-796-6615 |
News Archive
Sleep disturbances in patients with current depressive or anxiety disorders are associated with poor work performance and absenteeism, a subanalysis of the Netherlands Study of Depression and Anxiety suggests.
Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery, today announced the initiation of a dose-finding study designed to evaluate the safety and efficacy of MP4OX treatment plus standard of care in severely injured trauma patients with lactic acidosis due to hemorrhagic shock.
Living with HIV often means living with chronic pain, but behavioral therapy could offer an effective alternative to opioids.
Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for Tarceva (erlotinib) for first-line use in people with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) activating mutations.
› Verified 5 days ago